Our comprehensive Respiratory Pathogen Panel detects 21 common and emerging respiratory pathogens in a single test, offering fast and accurate results to support early diagnosis and treatment. This advanced molecular assay identifies viral and bacterial agents responsible for respiratory illnesses, including COVID-19, Influenza A and B, H1N1, H3N2, Parainfluenza viruses, Respiratory Syncytial Virus (RSV), Adenovirus, Rhinovirus/Enterovirus, Human Metapneumovirus, Mycoplasma pneumoniae and more among others. Ideal for use in hospitals, clinics, and urgent care settings, the panel enables clinicians to differentiate between pathogens with overlapping symptoms, ensuring appropriate and timely treatment decisions. With results typically available within hours, this panel enhances patient care while minimizing the spread of infection in community and healthcare environments. Early detection is key—our respiratory panel delivers the precision and speed needed for today’s fast-paced clinical environments.